Skip to main content

Animations

MJFF Publications

3571 - 3580 of 9038 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2024
  • 2024
  • 2025
  • 2022
  • Summary Details
    OPEN
    Title: Aβ oligomer concentration in mouse and human brain and its drug-induced reduction ex vivo
    Journal Name: Cell Reports Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.xcrm.2022.100630
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Heart-brain synchronization breakdown in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00323-w
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Women Caring for Husbands Living with Parkinson’s Disease: A Phenomenological Study Protocol
    Journal Name: Journal of Personalized Medicine
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/jpm12050659
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Image Quantification for TSPO PET with a Novel Image-Derived Input Function Method
    Journal Name: Diagnostics
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/diagnostics12051161
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Effects of Alzheimer’s genetic risk scores and CSF biomarkers in de novo Parkinson’s Disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00317-8
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson’s Disease: Clinical Trial Post Hoc Analyses
    Journal Name: Neurology and Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s40120-022-00332-0
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa‐Induced Dyskinesia
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29960
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Investigating the Protective Role of the Mitochondrial 2158 T > C Variant in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29892
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Identification of GGC Repeat Expansions in ZFHX3 among Chilean Movement Disorder Patients
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.30242
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Uncovering clinical and radiological asymmetry in progressive supranuclear palsy—Richardson’s syndrome
    Journal Name: Neurological Sciences
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s10072-022-05919-x
    Citation Count: 7
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.